The connection between estrogen and histamine is biologically plausible, but it is weaker than most online explanations suggest. In laboratory experiments, estradiol can make mast cells more reactive, and a few small human studies hint that allergic responses shift across the menstrual cycle.
What has not been shown is that high estrogen, low estrogen or menopause causes dietary histamine intolerance, or that estrogen and histamine drive each other in a self-sustaining loop inside the human body.
Where the strongest evidence sits
The best-known mechanistic work is a 2007 study by Zaitsu and colleagues. They used mast-cell and basophil cell lines plus primary mast cells from mice. At physiological concentrations, estradiol acted through estrogen receptor-alpha, increased calcium influx, promoted mediator release and enhanced IgE-dependent degranulation.
That finding supports an estrogen–mast-cell connection. It shows that estradiol can modulate mast-cell signaling and strengthen activation in experimental systems, but it does not establish dietary histamine intolerance.
It does not show what happens in a person eating a meal. Mast cells in a dish or in mice are not the same thing as the gut handling dietary histamine. Nothing in this work supports saying that estrogen always releases histamine, that it causes histamine intolerance, or that it causes mast cell activation syndrome.
This distinction matters because the three ideas get blurred online. Mast-cell activation and allergic responsiveness are one question. Dietary histamine intolerance, where symptoms are attributed to histamine from food, is another.
If you want the wider picture of how those conditions differ, our guide to MCAS and histamine intolerance covers it.
Can histamine raise estrogen?
This is the second half of the supposed loop, and the evidence is thin. In a 1993 study, Bódis and colleagues cultured human granulosa cells taken from 17 women undergoing IVF. Histamine increased estradiol secretion in a dose-dependent way, and an H1 antagonist blocked the effect.
That points to a possible mechanism inside ovarian cells. It is still cell-culture evidence from a single small study. It does not show that histamine circulating in the body, or histamine from food, raises ovarian estrogen enough to matter in a living person.
So a reverse pathway is biologically conceivable but unproven. Both directions have experimental cellular evidence, but no clinical study has shown that they form a self-reinforcing systemic loop in people.
Is the feedback loop proven?
No. A loop would require estrogen to raise histamine activity, histamine to raise estrogen, and the two effects to reinforce each other in a way that produces symptoms. At the moment there is experimental support for one direction, in-vitro support for the other, and no clinical study showing the full circuit in humans.
Calling it a “vicious cycle” therefore turns a hypothesis into a fact. It may turn out to be partly right. It has not been demonstrated.
What about DAO?
A common version of the theory says estrogen lowers diamine oxidase (DAO), the enzyme that helps break down histamine from food, so high estrogen leaves you less able to clear it. The human data are more complicated than that.
Hamada and colleagues measured serum DAO in 36 healthy women during the follicular and luteal phases. Serum DAO was significantly higher in the luteal phase. So cycle phase can affect a DAO blood measurement, but the direction does not fit a simple “estrogen suppresses DAO” rule.
A few cautions follow from this:
- Serum DAO is a blood measurement, not a direct reading of DAO activity in the gut lining.
- A change across the cycle does not mean the change causes symptoms.
- It is not a test that diagnoses histamine intolerance.
Pregnancy is sometimes offered as extra proof. Circulating DAO rises early in pregnancy, but a 2018 study by Velicky and colleagues traced it to extravillous trophoblasts, which are placental cells. That makes pregnancy a poor example of estrogen raising DAO, and it should not be used as one.
A 2025 review of dietary management in histamine intolerance mentions menstrual-cycle variation in serum DAO, animal evidence that estrogen may regulate DAO, estrogen-related mast-cell reactivity, and the possibility that symptoms are influenced by menstruation or menopause. It is a useful, cautious summary. It is not proof of causation, and the animal and tissue effects it describes depend on context. For the enzyme basics, see our page on the DAO enzyme and histamine.
What do human cycle studies show?
Two small studies are often cited, and they do not fully agree. Kalogeromitros and colleagues studied 15 atopic women who menstruated and 15 healthy controls. Skin-prick responses to histamine, morphine and allergen were larger around days 12 to 16 of the cycle, which corresponds to mid-cycle and peak estrogen.
Kirmaz and colleagues studied 42 women with seasonal allergic rhinoconjunctivitis. Allergen skin-test responses were greatest at mid-cycle, but skin reactivity to histamine itself did not vary through the cycle.
Put side by side, these findings are small and inconsistent. One suggests that even the response to histamine can change, the other suggests the shift is in the allergen response rather than in histamine sensitivity.
Both are skin tests in people with or without allergy. Neither is a study of food-histamine symptoms. They support the idea that hormones may influence allergic reactivity in some people. They do not support a rule that everyone with histamine-related symptoms flares at ovulation or before a period.
Low estrogen, menopause and “estrogen dominance”
The question people search for is usually whether low estrogen causes histamine intolerance. Current evidence does not establish that, and it does not establish menopause as a cause of dietary histamine intolerance either.
A 2026 review by Valerieva and colleagues concluded that changing estrogen and progesterone levels may influence mast-cell activity and how allergic disease shows up during menopause. The same review notes that the mechanisms are still poorly understood and that evidence-based, menopause-specific management is limited. That is a reason to take midlife symptom changes seriously, not a reason to name estrogen as the cause.
“Estrogen dominance” deserves the same caution. The phrase circulates widely online, but it is not a validated diagnosis, and it has not been shown to explain or cause histamine intolerance. Because the idea is unproven, this article does not recommend progesterone, DIM, calcium-D-glucarate or any “estrogen detox” approach.
Should you change hormone therapy because of histamine symptoms?
No. Current evidence does not justify starting, stopping or changing prescribed estrogen or hormone replacement therapy specifically to treat histamine intolerance. Decisions about hormone therapy depend on your age, health history, symptoms and risks, and they belong with a clinician who knows your situation.
If you suspect your prescription and your symptoms are linked, raise it with the prescriber rather than adjusting anything yourself. Timing alone cannot tell you whether the hormone, another ingredient, an unrelated condition or coincidence is responsible.
If your symptoms seem to follow your cycle
If you notice symptoms changing at certain points in the month, the pattern is worth recording even though it does not prove a mechanism. A cycle pattern does not diagnose histamine intolerance or MCAS, and the 2021 professional guideline on suspected reactions to ingested histamine stresses that no single reliable test exists, that serum DAO is inconclusive on its own, and that symptom reproducibility can be poor.
What helps is a clearer record, not a theory. For a few cycles you can track:
- the days of your cycle alongside when symptoms start
- what you ate and drank, and when
- medications and supplements, including any hormonal ones
- sleep, stress and anything else that changed that week
Bring the pattern to a clinician who can look at the whole picture, including allergy, other medical causes and your medicines.
Our guide to histamine intolerance symptoms explains why these symptoms are so nonspecific, and the overview of what causes histamine intolerance covers the better-supported explanations.
What the evidence means for estrogen and histamine
Estrogen can influence mast cells in experiments, and cycle phase may nudge allergic reactivity in some women. Those findings are enough to call the connection plausible. They are not enough to say that estrogen causes histamine intolerance, that histamine raises estrogen in your body, or that the two form a proven loop.
If your symptoms seem hormonal, treat that as something worth tracking and discussing, not as a diagnosis you need to act on alone.
References
- Zaitsu M, Narita S-I, Lambert KC, et al. Estradiol activates mast cells via a non-genomic estrogen receptor-alpha and calcium influx. Mol Immunol. 2007;44(8):1977-1985.
- Kalogeromitros D, Katsarou A, Armenaka M, et al. Influence of the menstrual cycle on skin-prick test reactions to histamine, morphine and allergen. Clin Exp Allergy. 1995;25(5):461-466.
- Kirmaz C, Yuksel H, Mete N, Bayrak P, Baytur YB. Is the menstrual cycle affecting the skin prick test reactivity? Asian Pac J Allergy Immunol. 2004;22(4):197-203.
- Bódis J, Tinneberg HR, Schwarz H, Papenfuss F, Török A, Hanf V. The effect of histamine on progesterone and estradiol secretion of human granulosa cells in serum-free culture. Gynecol Endocrinol. 1993;7(4):235-239.
- Hamada Y, Shinohara Y, Yano M, et al. Effect of the menstrual cycle on serum diamine oxidase levels in healthy women. Clin Biochem. 2013;46(1-2):99-102.
- Reese I, Ballmer-Weber B, Beyer K, et al. Guideline on management of suspected adverse reactions to ingested histamine. Allergol Select. 2021;5:305-314.
- Jackson K, Busse W, Gálvez-Martín P, Terradillos A, Martínez-Puig D. Evidence for Dietary Management of Histamine Intolerance. Int J Mol Sci. 2025;26(18):9198.
- Valerieva E, Vasileva M, Baynova K, et al. Women hormones and hypersensitivity: allergic diseases in menopause. Front Allergy. 2026;7:1777688.
- Velicky P, Windsperger K, Petroczi K, et al. Pregnancy-associated diamine oxidase originates from extravillous trophoblasts and is decreased in early-onset preeclampsia. Sci Rep. 2018;8(1):6342.
